AVR

1.29%

$18.31 anteris technologies ltd

When it comes to fast talking, "promise the world" everything...

First 15 Last

Share
Profile

Follow
asxunsullied

1,424 Posts.

148

10/07/20

09:53

Post #: 45770558
Share

Originally posted by Eire2011: ↑

Whether you believe that AVR will have a CR or that they will sign a partnership with an up front payment and milestones you should still be able to see this announcement for what it is.

Despite the usual cynics (and understandably so) the fact that Credit Suisse are involved is very positive. These guys are big investors in the likes of Medtronic and Edwards and cover the TAVR space extensively. They have previously mentioned AVR (unpaid) in research notes, the same notes where they discuss the Titans in the industry (Edwards, Medtronic and Boston Scientific)

Very few investors probably realise that only two weeks ago one of our Advisory Board members became Vice President and Chief Medical Officer for Medtronic’s structural heart division. This is a prominent TAVR MD that would be in charge of approving the science of any prospective partner. Popma has contributed to the DurAVR valve for Anteris. This is very big IMHO. It’s probably no coincidence that Medtronic Just today released a video talking with Doctor Paul Sorajja MD - Abbott Northwestern Hospital about a TAVR patient story. You see DR Jeffrey Popma and DR Paul Sorajja are Anteris Ad Board buddies.

Anyway, I digress, back to the announcement and the important points for me are:

* We will get an update on the TAVR program
* We will get an update on the SAVR trial. This means we should have about 8 patients or at least 50% enrolled. This result will be meaningful.
* On top of all of this we get the opportunity to hear from 3 of the most renowned TAVR MD’s in the world talk about the challenges faced by the current TAVR valves and how Anteris may provide the solution. This market is a multi billion dollar market.

This announcement (IMHO) is significant and will provide lots of interesting and important information provided by experts in the TAVR field.

I think this announcement is more important than the market gives it credit for and look I forward to the presentation and associated news it will provide.

DYOR and Not advice.

Expand

When it comes to fast talking, "promise the world" everything Yanks (American Hustle anyone?), and associated merchant bankers and brokers, I would now only act in the future (allocating capital and giving them more of my money) after "Seeing is believing"... Sorry about that E - call me cynical (sure) but when it comes to the "proof is in the pudding" (aka making money for shareholders -not everyone else), this outfit has been "full of it" (like the many yanks who have spruiked it before) for years... Just my opinion. My goodness I hope for your sake I am finally proven wrong E.. IMO!!!

Last edited by asxunsullied: 10/07/20

AVR Price at posting: $5.30 Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

RCE

Recce's R327 found effective against E.coli during clinical trial

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

There are more pages in this discussion • 13 more messages in this thread...

First 15 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $18.31		Change -0.240(1.29%)		Mkt cap ! $351.9M

Open	High	Low	Value	Volume
$18.80	$19.15	$18.20	$159.7K	8.611K

Buyers (Bids)

No.	Vol.	Price($)
1	73	$18.31

Sellers (Offers)

Price($)	Vol.	No.
$18.33	90	1

View Market Depth

No.	Vol.	Price($)
1	150	18.100
1	100	18.050
1	250	18.010
2	2010	18.000
1	55	17.910

Price($)	Vol.	No.
19.000	500	1
20.000	2950	4
20.120	420	1
20.200	309	1
20.400	678	1

Last trade - 16.10pm 28/06/2024 (20 minute delay)

AVR (ASX) Chart

When it comes to fast talking, "promise the world" everything...

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Ava Risk Group expands US presence with A$0.7M Substation Deal

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Recce's R327 found effective against E.coli during clinical trial

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

When it comes to fast talking, "promise the world" everything...

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Ava Risk Group expands US presence with A$0.7M Substation Deal

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Recce's R327 found effective against E.coli during clinical trial

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News